Novo Nordisk renews LifeScan partnership:
This article was originally published in Clinica
LifeScan, Johnson & Johnson's diabetes monitoring division, has announced a new alliance with Novo Nordisk, a Danish insulin producer. Under the terms of the agreement both companies will develop and market "unique devices" for use by people with diabetes, who must inject with insulin daily. The two companies reached their first joint marketing alliance in 1995.